Skarleas Christos Radiation OncologistAssociate Director, Gamma Knife Department and Radiation Oncology Centre HYGEIA
Education & Academic Qualifications
- National & Kapodistrian University of Athens, School of Medicine – MD, 1995
- Radiation Oncology fellow, Areteion Hospital, 2001
- Medical specialization to Radiosurgery of Brain, Gamma Knife, University of Pittsburgh Medical Center, UPMC, USA, 2008
Under preparation of PhD : “Clinical Evaluation of intravenous use of Disodium Pamidronate (AREDIA) in combination with Radiotherapy for bone metastases». School of Medicine, National & Kapodistrian University of Athens, Greece
Fellowship in Societies, Membership in Journal Editorial Committees
European Society of Therapeutic Radiation Oncology (ESTRO) (member)
American Society of Clinical Oncology (ASCO) (member)
European Society for Palliative Care (ESPC) (member)
International Society of Radiosurgery (ISRS) (member)
Hellenic Society for Fertility Preservation (HSFP) (founding member)
Greek Society of Head and Neck Oncology (member)
Medical Association of Piraeus (member)
Greek Society of Radiation Oncology (member)
Greek Society of Digestive Oncology (member)
Greek Society of Palliative Care (member)
Greek Society of Supportive Care Orally to Cancer Patients (founding member)
Associate Director Gamma Knife Department, Hygeia Hospital, Athens, Greece, December 2014
Radiosurgeon: Stereotactic Radiosurgery & Stereotactic Radiotherapy, Hygeia Hospital, Athens, Greece, November 2007
Radiation Oncologist, Euromedica, Athens, Greece, May 2003
Radiation Oncologist: Gamma Knife Department & Radiation Oncology Center, Hygeia Hospital, Athens, Greece, November 2001
Radiation Oncology Fellow, Aretaieio Hospital, Athens, Greece, October 1996-December 2000
Social Contribution Program of Armed Forces, March 1995 – September 1996
He has taught in many teaching seminars for medical students, oncology trainees and medical – nursing staff.
Speech on: Radiotherapy Prostate Cancer. Radiology Athens University Laboratory. June 2000
Speech on: Inflammatory and neoplasmatic diseases of the colon. –Radiotherapy of rectal cancer. December 2005
Speech on: Breast Cancer – Radiotherapy after Mastectomy. Training workshop for specialists Radiation Oncology. May 2006
Speech on: G-Knife in brain metastasis. 4th Seminar for the treatment of lung cancer. May 2007
Speech on: Newer data radiotherapy in the treatment of malignant tumors. Advanced courses of surgical department. Asklipiion Voulas, Greece. February 2011
Clinical & Research Interest
Radiation Therapy 6- 18 MV X-rays
3D, IMRT, VMAT, IGRT, Adapted Radiotherapy (CBCT, EPID)
Stereotactic Radiotherapy (brain & body) SRT-SBRT
Gamma knife brain radiosurgery
Radiotherapy with 6, 9, 12, 15 or 18 MeV electron beams
Brachytherapy HDR Afterloading (Micro Selectron)
Oncology council – Tumor Board
Head & Neck tumors
Ιmage (CBCT-EPID) – Computer Guided 3D – IMRT Radiotherapy –Temodal
Stereotactic Radiotherapy SRT-SBRT
Stereotactic Radiosurgery SRS
Stereotactic Radiosurgery Meningiomas and Acoustic Neuromas with Gamma Knife
Brain Radiosurgery. Combined Stereotactic Radiotherapy and Gamma Knife to brain metastasis
Study of the role of PET/CT in Radiotherapy Planning of Lymphoma
Mosaiq Network Communications and Quality Assurance
Honors & Awards
Award of distinction from the Greek Army for my services as a doctor in the Social Contribution Program of Armed Forces. September 1996
Author of the chapter: The Role of PET/CT in Radiotherapy Planning of Lymphoma at “Imaging of lymphomas with FDG PET/CT” Atlas, Springer books.
Hypofractionated irradiation for gliomas with 45.5Gy in 13 fractions: a retrospective study. Kouloulias V1, Zygogianni A, Kouvaris J, Platoni K, Georgakopoulos J, Boviatsis E, Beli I, Tolia M, Antypas C, Karaiskos P, Scarleas C, Asimakopoulos C, Pantelakos P, Kelekis N., J Neurosurg Sci. 2015 Dec;59(4):447-53.
Management of brain metastasis in a patient with advanced epithelial ovarian carcinoma by gamma-knife radiosurgery. Nikolaou m., Stamenkovic S.,Stergiou C., Skarleas C., Torrens M., Srp Arh Celok Lek. 2015 Mar-Apr;143(3-4):205-9.
Investigating the clinical aspects of using CT vs CT-MRI images during organ delineation and treatment planning in prostate cancer radiotherapy. Tzikas A., Karaiskos P., Papanikolaou N., Sandilos P., Koutsouveli E., Lavdas E., Skarleas C., Dardoufas K., Lind BK., Mavroidis P. Technol Cancer Res Treat., 10, 231-42 (2011).
Herpes simplex virus-1 (HSV-1) infection in radiation-induced oral mucositis. Nicolatou-Galitis O, Athanassiadou P, Kouloulias V, Sotiropoulou-Lontou A, Dardoufas K, Polychronopoulou A, Gonidi M, Kyprianou K, Kolitsi G, Skarleas C, Pissakas G, Papanikolaou IS, Kouvaris J. Support Care Cancer. 2006 Jul:14(7):753-62. Epub 2006 Jan 10.
Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy. O .Nicolatou -Galitis, A. Velegraki, A. Sotiropoulou – Lontou, K. Dardoufas, V.Kouloulias, K. Kyprianou, G. Kolitsi, C. Skarleas, G. Pissakas, VS. Papanicolaou, J. Kouvaris. Supportive Care Cancer. 2006 Jan:14(1):44-51. Epub 2005 Jun 10.
Response to radiotherapy in brain metastasis and survival of patients with non-small cell lung cancer. D. Antoniou, K. Kyprianou, G. Stathopoulos, C. Skarleas, G. Kolitsi, M. Veslemes, J. Dimitroulis, P. Giamboudakis, K. Marosis, O. Armenaki, C. Papageorgiou, C. Katis. Oncology Rep. 2005 Sep:14(3):733-6.
The use of tolouidine blue as a diagnostic aid in the follow – up of patients treated with radiotherapy for oral carcinoma. K. Dardoufas, O. Nicolatou – Galitis, G. Kolitsi, K. Kyprianou, G. Pissakas, C. Skarleas, P. Mavroidi, G. Nikolatos, V. Papanicolaou, A. Sotiropoulou – Lontou. Radiotherapy & Oncology, September 2002, VOL.64 (Suppl 1).
Life expectancy-quality of life after palliative radiotherapy for patients with brain metastases. C. Kyprianou, C. Skarleas, G. Kolitsi, E. Morianou, B. Taranto, S. Kosmidou, G. Stathopoulos, G. Manolakis, S. Rigatos. Radiotherapy & Oncology, September 2002, VOL.64 (Suppl 1).
A Phase II study evaluating the efficacy and safety of Temozolamide (tmz) post and concurrently with radiotherapy (RT) in the treatment of patients with previously untreated high grade gliomas. A.Miliadou, C.Dardoufas, I.Kouvaris, M.Balafouta, C.Skarleas, I.Kokakis, P.Mauroidi, S.Vosdoganis, D.Pandoleon, L.Vlachos. European Journal of Cancer (EJC), October 2001, VOL.37 (Suppl.6)
A Phase II study evaluating the efficacy and safety of Temozolamide Post-Radiation in the Treatment of patients with previously untreated high grade Gliomas. A.Miliadou, C.Dardoufas, I.Kouvaris, M.Balafouta, V.Kouloulias, C.Skarleas, I.Kokakis, P.Mauroidi, K.Mistakidou, L.Vlachos. Neuro-Oncology, July 2000, VOL.2 (Suppl.1)